Abiopharma

New Form 144 - Axsome Therapeutics, Inc. Filed: 2025-08-29 AccNo: 0001921094-25-001050 Size: 6 KB

Equillium - Equillium to Participate in the Cantor Global Healthcare Conference 2025

New Form 425 - NLS Pharmaceutics Ltd. Filed: 2025-08-29 AccNo: 0001213900-25-082554 Size: 35 KB

AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Director Bhatia Sangeeta N. 🔴 sold 266 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX) at $386.69 Transaction Date: Aug 27, 2025 | Filing ID: 000222

New Form 8-K - Azitra, Inc. Filed: 2025-08-29 AccNo: 0001493152-25-012476 Size: 243 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

SMITH BRIAN TRAVIS 🟢 acquired 4.0K shares (1 derivative) of EASTMAN CHEMICAL CO (EMN) at $68.34 Transaction Date: Aug 27, 2025 | Filing ID: 000007

New Form 6-K - NLS Pharmaceutics Ltd. Filed: 2025-08-29 AccNo: 0001213900-25-082550 Size: 34 KB

New Form 144 - Ascendis Pharma A/S Filed: 2025-08-29 AccNo: 0001964306-25-000340 Size: 4 KB

New Form SCHEDULE 13D/A - RETRACTABLE TECHNOLOGIES INC Filed: 2025-08-29 AccNo: 0001104659-25-085625 Size: 6 KB

Notification from CEL SCI CORP

New Form DEFA14A - Monogram Technologies Inc. Filed: 2025-08-29 AccNo: 0001104659-25-085621 Size: 40 KB

New Form 8-K - Monogram Technologies Inc. Filed: 2025-08-29 AccNo: 0001104659-25-085618 Size: 220 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 144 - AGILENT TECHNOLOGIES, INC. Filed: 2025-08-29 AccNo: 0001959173-25-005641 Size: 5 KB